Evidence map›Paper›PMID 17492941›Full record

ArticleThe Biochemical journal2007

Phospholipase C beta3 is a key component in the Gbetagamma/PKCeta/PKD-mediated regulation of trans-Golgi network to plasma membrane transport.

Alberto M Díaz Añel

Open access · bronzeAbstract read
In one paragraph

Article in The Biochemical journal, 2007. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 35 papers.

0numbers the graph read from it
0cells of the map it votes in
35citing papers in PubMed
2.1field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

35 citing papers in PubMed, 72 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Review
  20. Components of the CtBP1/BARS-dependent fission machinery.Histochemistry and cell biology · 2013
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author at 1 institution in 1 country.

Alberto M Díaz AñelCenter for Molecular Genetics, University of California at San Diego, San Diego, CA, USA. adiazanel@immf.uncor.edu
Instituto de Investigación Médica Mercedes y Martín Ferreyra · AR

Funding

MECHANISM OF GOLGI BREAKDOWN DURING MITOSISR01GM046224 · NIGMS · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI MALHOTRA, VIVEK · 1991 to 2007
$2.7M
MECHANISMS OF GOLGI VESICULATION DURING MITOSISR01GM053747 · NIGMS · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI MALHOTRA, VIVEK · 1999 to 2007
$2.5M
NIGMS NIH HHS GM46224NIGMS NIH HHS GM53747NIGMS NIH HHS R01 GM046224NIGMS NIH HHS R01 GM053747
6 · The paper itself

Abstract

The requirement of DAG (diacylglycerol) to recruit PKD (protein kinase D) to the TGN (trans-Golgi network) for the targeting of transport carriers to the cell surface, has led us to a search for new components involved in this regulatory pathway. Previous findings reveal that the heterotrimeric Gbetagamma (GTP-binding protein betagamma subunits) act as PKD activators, leading to fission of transport vesicles at the TGN. We have recently shown that PKCeta (protein kinase Ceta) functions as an intermediate member in the vesicle generating pathway. DAG is capable of activating this kinase at the TGN, and at the same time is able to recruit PKD to this organelle in order to interact with PKCeta, allowing phosphorylation of PKD's activation loop. The most qualified candidates for the production of DAG at the TGN are PI-PLCs (phosphatidylinositol-specific phospholipases C), since some members of this family can be directly activated by Gbetagamma, utilizing PtdIns(4,5)P2 as a substrate, to produce the second messengers DAG and InsP3. In the present study we show that betagamma-dependent Golgi fragmentation, PKD1 activation and TGN to plasma membrane transport were affected by a specific PI-PLC inhibitor, U73122 [1-(6-{[17-3-methoxyestra-1,3,5(10)-trien-17-yl]amino}hexyl)-1H-pyrrole-2,5-dione]. In addition, a recently described PI-PLC activator, m-3M3FBS [2,4,6-trimethyl-N-(m-3-trifluoromethylphenyl)benzenesulfonamide], induced vesiculation of the Golgi apparatus as well as PKD1 phosphorylation at its activation loop. Finally, using siRNA (small interfering RNA) to block several PI-PLCs, we were able to identify PLCbeta3 as the sole member of this family involved in the regulation of the formation of transport carriers at the TGN. In conclusion, we demonstrate that fission of transport carriers at the TGN is dependent on PI-PLCs, specifically PLCbeta3, which is necessary to activate PKCeta and PKD in that Golgi compartment, via DAG production.

Indexed as

AnimalsBenzenesulfonamidesCell MembraneDiglyceridesEnzyme ActivationEstrenesGTP-Binding Protein beta SubunitsGTP-Binding Protein gamma SubunitsHeLa CellsHumansIsoenzymesMembrane GlycoproteinsModels, BiologicalPhospholipase C betaPhosphorylationProtein Kinase C1-(6-((3-methoxyestra-1,3,5(10)-trien-17-yl)amino)hexyl)-1H-pyrrole-2,5-dione2,4,6-trimethyl-N-(meta-3-trifluoromethylphenyl)benzenesulfonamideBenzenesulfonamidesDiglyceridesEstrenesG protein, vesicular stomatitis virusGTP-Binding Protein beta SubunitsGTP-Binding Protein gamma SubunitsIsoenzymesMembrane GlycoproteinsPhospholipase C betaPLCB3 protein, humanPlcb3 protein, ratProtein Kinase Cprotein kinase C etaprotein kinase DPyrrolidinonesRNA, Small InterferingSulfonamidesType C PhospholipasesViral Envelope Proteins

Identifiers

PMID17492941
PMCPMC1948997
OpenAlexW2080001787

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.